Peripheral artery disease (PAD) is one of the most common vascular disorders worldwide, affecting millions of people and significantly increasing the risk of heart attack, stroke, and limb loss. As the prevalence of diabetes, hypertension, obesity, and aging-related vascular disorders continues to rise, demand across the PAD treatment market, peripheral vascular disease market, and vascular intervention devices market is accelerating. These trends are contributing to the strong growth of the Peripheral Artery Disease Market, supported by advances in minimally invasive therapies, improved diagnostics, and expanding access to vascular care.

The global peripheral artery disease market was valued at USD 5.11 billion in 2024 and is expected to grow at a CAGR of 7.5% from 2025 to 2034. The market is projected to reach USD 5.49 billion in 2025 and rise to USD 10.53 billion by 2034.

Growing Demand in the PAD Treatment Market

The PAD treatment market is expanding as healthcare providers emphasize early diagnosis and timely intervention to reduce disease progression and prevent serious complications. PAD occurs when narrowed arteries restrict blood flow to the legs and other extremities, typically due to atherosclerosis.

Common symptoms include:

• Leg pain while walking (claudication)
• Numbness or weakness in the legs
• Slow-healing wounds
• Cold feet or lower limbs
• Reduced mobility

Treatment approaches depend on disease severity and generally include lifestyle modifications, medications, minimally invasive procedures, and surgical interventions.

Medical therapies commonly include:

• Antiplatelet medications
• Cholesterol-lowering drugs
• Blood pressure management
• Diabetes control
• Smoking cessation programs

For advanced disease, endovascular procedures such as angioplasty, stent placement, atherectomy, and bypass surgery are increasingly preferred due to improved outcomes and faster recovery.

Peripheral Vascular Disease Market Continues to Expand

The peripheral vascular disease market includes products and therapies designed to diagnose, monitor, and treat disorders affecting blood vessels outside the heart and brain. Rising rates of cardiovascular disease, obesity, and metabolic disorders are significantly increasing the patient population requiring vascular care.

Major factors supporting market growth include:

• Increasing elderly population
• Growing prevalence of diabetes
• Rising incidence of hypertension
• Improved vascular screening programs
• Greater awareness of cardiovascular health

Healthcare providers are placing greater emphasis on early detection through ankle-brachial index (ABI) testing, duplex ultrasound, CT angiography, and MR angiography. Earlier diagnosis allows physicians to initiate treatment before severe complications such as critical limb ischemia or amputation occur.

Vascular Intervention Devices Market Driving Innovation

The vascular intervention devices market has experienced remarkable technological progress over the past decade. Minimally invasive devices now enable physicians to restore blood flow with greater precision while minimizing procedural risks.

Key vascular intervention devices include:

• Balloon angioplasty catheters
• Drug-coated balloons
• Peripheral stents
• Atherectomy devices
• Guidewires
• Imaging catheters

Drug-coated balloons and next-generation stents are improving long-term vessel patency while reducing restenosis rates. According to Polaris Market Research, the device segment accounted for approximately 62% of market revenue in 2024, reflecting the widespread adoption of minimally invasive vascular interventions.

Continuous innovation in imaging-guided procedures, biodegradable stents, intravascular lithotripsy, and robotic-assisted interventions is expected to further enhance procedural success and patient outcomes.

Growth Drivers of the Peripheral Artery Disease Market

Several factors continue to accelerate the expansion of the Peripheral Artery Disease Market.

Rising Burden of Diabetes and Hypertension

These chronic conditions significantly increase the risk of atherosclerosis and PAD, expanding the number of patients requiring long-term treatment.

Aging Global Population

Older adults are more susceptible to peripheral artery disease, increasing demand for vascular diagnostics and intervention procedures.

Preference for Minimally Invasive Procedures

Patients and physicians increasingly favor catheter-based therapies because they offer reduced recovery times, lower complication rates, and shorter hospital stays.

Technological Advancements

Innovations in vascular imaging, drug-coated technologies, atherectomy systems, and bioresorbable devices continue improving treatment effectiveness.

Increased Public Awareness

Public health initiatives promoting cardiovascular screening and early diagnosis are enabling earlier treatment and reducing severe complications.

Market Segmentation Overview

The Peripheral Artery Disease Market is segmented by treatment type, distribution channel, and end user.

By Treatment Type

• Devices
• Drugs

The device segment dominated the market in 2024 due to the increasing adoption of angioplasty balloons, stents, and atherectomy systems for minimally invasive treatment.

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Hospital pharmacies accounted for the largest market share because complex PAD interventions are primarily performed in hospital settings.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/peripheral-artery-disease-market

Key Players

• Abbott
• AngioDynamics
• B. Braun SE
• Bayer AG
• BD
• Biotronik
• Boston Scientific Corporation
• Cardinal Health
• Endologix LLC
• iVascular
• Johnson & Johnson
• Koninklijke Philips N.V.
• Medtronic
• Terumo Corporation

Regional Analysis

North America currently leads the Peripheral Artery Disease Market, supported by advanced healthcare infrastructure, widespread adoption of endovascular procedures, favorable reimbursement policies, and a high prevalence of cardiovascular risk factors.

Europe also represents a significant market due to its aging population and well-established vascular care programs. Meanwhile, Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by improving healthcare infrastructure, increasing diabetes prevalence, expanding access to minimally invasive therapies, and growing government investment in cardiovascular care.

Future Outlook

The future of the PAD treatment market, peripheral vascular disease market, and vascular intervention devices market will be shaped by continuous innovation in minimally invasive technologies, artificial intelligence-assisted diagnostics, advanced imaging systems, and next-generation vascular implants.

Emerging technologies such as bioresorbable scaffolds, drug-coated devices, intravascular lithotripsy, and AI-powered diagnostic platforms are expected to improve procedural precision and long-term clinical outcomes.

As awareness of peripheral artery disease continues to increase and healthcare systems prioritize early intervention, the Peripheral Artery Disease Market is expected to experience sustained growth. Ongoing investments in vascular technologies and preventive cardiovascular care will further strengthen the market while improving patient outcomes and reducing the global burden of vascular disease.

More Trending Latest Reports By Polaris Market Research:

Thyroid Cancer Diagnostics Market

Healthcare Simulation Market

MENA Fabry Disease Treatment Market

Autoimmune Disease Diagnostics Market

Dental Contouring Market

Europe Facial Injectables Market

U.S. Animal Wound Care Market

Plasmid Purification Market